Trial Details

COMPLETED
Basic Information
Clinical ID c4099
Identifier NCT01053962
Trial Title SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Chronic Idiopathic Constipation
Interventions DRUG: SP-304 0.3 mg|DRUG: SP-304 1.0 mg|DRUG: SP-304 3.0 mg|DRUG: SP-304 9.0 mg|DRUG: Placebo
Participant Information
Sponsor Bausch Health Americas, Inc.
City Mesa
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2010-03
Primary Completion Date 2010-08
Completion Date 2010-08